[{"type": "title", "data": "NEURO Thrombolytic Therapy for Stroke"}, {"type": "category", "data": "Admit/Transfer/Discharge"}, {"type": "note", "data": "Review eligibility criteria and if patient NOT eligible for thrombolysis refer to NEURO Stroke Ischemic without tPA Admission "}, {"type": "note", "data": "Eligibility Criteria Indications: (ALL 3 must be met) -Clearly defined onset less than or equal to 4.5 hours AND -Significant measurable neurological deficit as per a recognized tool: e.g. NIH Stroke Scale score AND -Baseline CT showing NO evidence of intracranial hemorrhage "}, {"type": "note", "data": "ABSOLUTE Contraindications: -History of intracranial hemorrhage, neoplasm, vascular malformation (except meningioma) or aneurysm -Stroke, intracranial surgery, or head injury within 3 months -Arterial puncture at a non-compressible site within 7 days -Symptoms of stroke suggestive of subarachnoid hemorrhage -Seizure with deficits which can all be attributed to posticital residual neurological impairments (i.e. Todd\u2019s Paralysis) rather than acute stroke -Evidence of active bleeding or acute trauma on examination -Acute bleeding diathesis -Persistent hypertension (BP greater than 185/110) despite treatment -Anticoagulant use within 48 hours and a prolonged PTT and/or INR greater than 1.7 (see below if patient presents 3 to 4.5 hours post onset of stroke symptoms) -Platelet count less than 100,000 x 109/L -Blood glucose less than 2.7 mmol/L or greater than 22 mmol/L -CT changes showing extensive, well developed infarct -Evidence of intracranial hemorrhage on pre-treatment non-contrast head CT "}, {"type": "note", "data": "Relative Contraindications: -Recent acute myocardial infarction (within previous 3 months) -Neurological signs clearing spontaneously; signs minor and isolated -Pregnancy -Within 14 days of major surgery or serious trauma (see below if patient presents 3 to 4.5 hours post onset of stroke symptoms) -Recent gastrointestinal or urinary tract hemorrhage (with previous 21 days) -Post myocardial infarction pericarditis or aortic dissection -Age under 18 years of age "}, {"type": "note", "data": "Precautions within 3 to 4.5 Hours following Onset of Stroke Symptoms: -Oral anticoagulant treatment -Age greater than 80 years -Severe hemispheric stroke as assessed clinically (NIHSS score greater than 25) or a stroke with major early infarct -CT signs involving more than one third of the middle cerebral artery territory -Combination of previous stroke and diabetes mellitus -Major surgery or trauma within the previous 3 months "}, {"type": "category", "data": "Patient Care"}, {"type": "order", "data": "Weight (Wt)", "value": "checked"}, {"type": "sentence", "data": "T;N, Once"}, {"type": "order", "data": "Vital Signs (VS)", "value": "checked"}, {"type": "sentence", "data": "T;N, As per protocol"}, {"type": "order", "data": "Neurological Vital Signs (NVS)", "value": "checked"}, {"type": "sentence", "data": "T;N, As per protocol"}, {"type": "order", "data": "Blood Pressure (BP)", "value": "checked"}, {"type": "sentence", "data": "T;N, As per protocol, Goal is SBP less than 185 mmHg over DBP less than 105 mmHg"}, {"type": "order", "data": "Conditional Order", "value": "checked"}, {"type": "sentence", "data": "T;N, If clinical deterioration occurs during the administration of t-PA: stop infusion, draw Hct, Hgb, PTT, INR, platelets and fibrinogen, do immediate CT Scan"}, {"type": "order", "data": "Notify Provider", "value": "checked"}, {"type": "sentence", "data": "T;N, Notify provider if BP not controlled by labetalol or hydralazine (if SBP greater than 180 mmHg or DBP is greater than 105 mmHg)"}, {"type": "order", "data": "Notify Provider", "value": "checked"}, {"type": "sentence", "data": "T;N, Notify physician if any signs of bleeding and/or if any neurological deficits"}, {"type": "category", "data": "Continuous Infusions"}, {"type": "order", "data": "Peripheral IV Insertion", "value": "checked"}, {"type": "sentence", "data": "T;N, 18 gauge preferred; infuse NS TKVO"}, {"type": "order", "data": "Peripheral IV Insertion", "value": "checked"}, {"type": "sentence", "data": "T;N, 18 gauge preferred; insert opposite arm of 1st line; saline Lock"}, {"type": "order", "data": "Sodium Chloride 0.9% intravenous solution", "value": "checked"}, {"type": "sentence", "data": "500, IV, T;N, 180 day(s), TKVO, 25 mL/hr"}, {"type": "category", "data": "Medications"}, {"type": "note", "data": "<FONT size=3 face=Calibri><FONT size=3 face=Calibri><P>Pre-Tissue Plasminogen Activator (t-PA)</P></FONT></FONT>"}, {"type": "note", "data": "labetalol and hydrALAZINE require specific monitoring, and can usually be given only in criticial care and step-down areas. Consult the parenteral drug therapy manual for further information "}, {"type": "note", "data": "If pre-treatment SBP greater than 185 mmHg or DBP greater than 110 mmHg give labetalol OR hydralAZINE "}, {"type": "note", "data": "labetalol is contraindicated in CHF, asthma or heart block "}, {"type": "order", "data": "labetalol", "value": ""}, {"type": "sentence", "data": "20 mg, IV, Injection, infused over 1-2 minutes, may repeat x1"}, {"type": "note", "data": "If heart rate is less than 60 bpm or if labetalol contraindicated, give hydrALAZINE "}, {"type": "order", "data": "hydrALAZINE", "value": ""}, {"type": "sentence", "data": "20 mg, IV, Injection, q15min, PRN, Hypertension"}, {"type": "note", "data": "Tissue Plasminogen Activator (t-PA) "}, {"type": "note", "data": "If SBP remains greater than 185 mmHg&nbsp;or DBP greater than 110 mmHg, DO NOT ADMINISTER t-PA "}, {"type": "note", "data": "alteplase (t-PA) total dose: 0.9 mg/kg (maximum 90 mg) "}, {"type": "order", "data": "alteplase 100 mg intravenous injection", "value": "checked"}, {"type": "sentence", "data": "0.09 mg/kg, IV, Injection, Once, 1 minute(s), For acute ischemic stroke"}, {"type": "order", "data": "alteplase 100 mg intravenous injection", "value": "checked"}, {"type": "sentence", "data": "0.81 mg/kg, IV, Injection, Once, 60 minute(s), For acute ischemic stroke"}, {"type": "note", "data": "For angioedema "}, {"type": "order", "data": "famotidine", "value": ""}, {"type": "sentence", "data": "20 mg, IV Push, Injection, Once"}, {"type": "order", "data": "diphenhydrAMINE", "value": ""}, {"type": "sentence", "data": "50 mg, IV Push, Injection, Once"}, {"type": "order", "data": "methylPREDNISolone sodium succinate", "value": ""}, {"type": "sentence", "data": "80 mg, IV Push, Injection, Once"}, {"type": "note", "data": "Post-Tissue Plaminogen Activator (t-PA) "}, {"type": "note", "data": "If SBP is greater than 180 mmHg or DBP is greater than 105 mmHg and after starting t-PA (alteplase) "}, {"type": "order", "data": "labetalol", "value": ""}, {"type": "sentence", "data": "10 mg, IV Push, Injection, q10min, PRN, Administer over: 2 minute(s)"}, {"type": "note", "data": "If heart rate less than 60 bpm or if labetalol contraindicated, give hydrALAZINE "}, {"type": "order", "data": "hydrALAZINE", "value": ""}, {"type": "sentence", "data": "20 mg, IV Push, Injection, q15min, PRN, Hypertension, for 180 day(s)"}, {"type": "order", "data": "acetaminophen", "value": "checked"}, {"type": "sentence", "data": "650 mg, PO, Tab, q4hr, PRN, Pain / Fever, for 180 day(s)"}, {"type": "order", "data": "dimenhyDRINATE", "value": "checked"}, {"type": "sentence", "data": "50 mg, IV, Injection, q4hr, PRN, Nausea, for 180 day(s)"}, {"type": "category", "data": "Laboratory"}, {"type": "note", "data": "Crossmatch and type if transfusion anticipated "}, {"type": "note", "data": "Refer to Administration of Blood Products (Multiphase) for blood transfusion"}, {"type": "note", "data": "Placeholder: Crossmatch"}, {"type": "order", "data": "TRANSFUSE Red Blood Cells Product", "value": ""}, {"type": "sentence", "data": "STAT, 4, Units"}, {"type": "order", "data": "TRANSFUSE Fresh Frozen Plasma Product", "value": ""}, {"type": "sentence", "data": "STAT, 4, Units"}, {"type": "note", "data": "Placeholder: cryoprecipitate"}, {"type": "order", "data": "TRANSFUSE Platelets Product", "value": ""}, {"type": "sentence", "data": "STAT, 1, Units"}, {"type": "order", "data": "CBC w/ Diff", "value": "checked"}, {"type": "sentence", "data": "Blood, STAT collect, T;N, Once"}, {"type": "order", "data": "Platelet Count", "value": "checked"}, {"type": "sentence", "data": "Blood, STAT collect, T;N, Once"}, {"type": "order", "data": "INR", "value": "checked"}, {"type": "sentence", "data": "Blood, STAT collect, T;N, Once"}, {"type": "order", "data": "PTT", "value": "checked"}, {"type": "sentence", "data": "Blood, STAT collect, T;N, Once"}, {"type": "note", "data": "Placeholder: E7 (Na, K, Cl, CO2, Urea, Cr, Glu)- Blood, STAT collect, T;N, Once "}, {"type": "category", "data": "Diagnostic Tests"}, {"type": "order", "data": "CT Head Multi w/o Contrast", "value": ""}, {"type": "sentence", "data": "T;N, P1 - STAT"}, {"type": "order", "data": "ECG Standard 12-Lead", "value": ""}, {"type": "sentence", "data": "T;N, P1 - STAT"}, {"type": "order", "data": "XR Chest 1", "value": ""}, {"type": "sentence", "data": "T;N, P1 - STAT"}, {"type": "order", "data": "CT Head Multi w/o Contrast", "value": ""}, {"type": "sentence", "data": "T;N, P1 - STAT, Reason For Exam: due to deterioration after t-PA administration"}, {"type": "category", "data": "Consults/Referrals"}, {"type": "note", "data": "If clinical deterioration occurs during the administration of t-PA (alteplase): obtain neurological/internist consult (if regional specialist unavailable, call Stroke Team at 1-604-707-3030) "}, {"type": "order", "data": "Consult to Critical Care", "value": "checked"}, {"type": "sentence", "data": "T;N, ICU admission"}]
